The Weizmann Institute’s Prof. Dan Yakir has won this year’s Israel Prize for Research in Geology, Earth Sciences and Atmospheric Sciences, for his groundbreaking insights into the impact of semi-arid forests on the global climate. “At the station he founded in the Yatir Forest, Prof. Yakir explores the interactions between the biosphere and the atmosphere, especially the ways in which vegetation influences the environment and the climate,” Education Minister Naftali Bennett tweeted.
April 02, 2019
Israel’s lunar lander – which Weizmann has been helping develop – is en route to the Moon. The XPRIZE Foundation, “inspired” by the effort, has announced creation of a new “Moonshot Award,” which the SpaceIL team will receive upon a successful landing.
March 28, 2019
Israel21C reports on 10 major Israeli research projects focused on circadian rhythm. Four projects are by Weizmann scientists: two by Prof. Gad Asher, one by Prof. Tsvee Lapidot, and one by Prof. Eran Segal.
March 25, 2019
The Jerusalem Post reports on a company established by a Weizmann Institute alum, Nir Erez, who left a job in big pharma to find a way to help cancer sufferers. His firm, Trial-In Pharma, connects patients to 20,000 clinical trials and compassionate use treatments worldwide.
March 24, 2019
On March 22, the Weizmann Institute of Science in Rehovot, Israel, and Institut Curie in Paris, France, two major world-class research institutes, signed an historic partnership that will allow their teams to work closely together to improve knowledge in the field of life sciences, particularly in the areas of physics and chemistry, and most specifically - in the field of cancer research. This is a milestone in the history of these two institutes that have been working together for 15 years, particularly in the field of biophysics.
March 22, 2019
Education Minister Naftali Bennett announced Wednesday that Professor Adi Kimchi of the Weizmann Institute of Science is this year’s winner of the Israel Prize for research in life sciences. Kimchi heads a lab that studies the complex processes of programmed death in living cells. The prize selection committee noted Kimchi’s pioneering work in isolating genes involved in cells’ self-destruction, a process that, among other things, helps the body suppress cancer development.
March 20, 2019
An anti-cancer therapy that has been developed by scientists at the Weizmann Institute of Technology will get a $10 million investment from a South Korean biopharmaceutical company that is traded on the Korea Stock Exchange. This is the Korean firm’s first investment in an Israeli venture, the Weizmann Institute said in a statement.
March 20, 2019
The Jerusalem Post reports on plant sciences research that was shared by American Committee CEO Dave Doneson in the second episode of his video series, “Weizmann in Focus.”
March 19, 2019
Berkeley Lab biochemist Mina Bissell has received two significant awards – including the 2019 Weizmann Women & Science Award – in recognition of her contributions to breast cancer biology and medicine.
March 19, 2019
©2019 American Committee for the Weizmann Institute of Science
